Status:
COMPLETED
Myocardial Blood Volume Measurement by Real-Time Myocardial Perfusion Echocardiography Correlates to Myocardial Compressibility by Cardiac Magnetic Resonance Imaging in Healthy Subjects
Lead Sponsor:
Mayo Clinic
Conditions:
Healthy Adults
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study is being done to find out the normal amount of blood within the heart muscle and the variations in this blood flow between a cardiac MRI and TTE.
Eligibility Criteria
Inclusion
- Age ≥ 18 years.
- Available for testing performed in Rochester, MN.
- Willing to undergo both an echocardiogram with RTMPE and CMR.
- Study subject providing consent.
Exclusion
- Adults \< 18 years.
- BMI \<30 kg/m\^2.
- Hypertension.
- Diabetes Mellitus.
- Stroke.
- Cardiomyopathy or structural heart disease.
- Known coronary artery disease or history of myocardial infarction.
- Contraindication to echo enhancement agent or gadolinium administration such as an allergy.
- Renal GFR \< 50 mL/mL.
- Females who are pregnant.
- Subject unwilling to consent.
Key Trial Info
Start Date :
February 9 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 11 2021
Estimated Enrollment :
115 Patients enrolled
Trial Details
Trial ID
NCT04724304
Start Date
February 9 2021
End Date
November 11 2021
Last Update
April 7 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo clinic Rochester
Rochester, Minnesota, United States, 55905